mRNA/SOL
Wynik | 28 |
|---|---|
Wol. – 24h | 678,56 $ |
Płynność | 2,1 tys. $ |
Posiadacze | 95 |
Audyty | |
Wiek | 2 dni |
FDV | 2 tys. $ |
Kap. rynkowa | 2 tys. $ |
| Adresy | |
|---|---|
| Pula | |
| mRNA | |
| SOL |  |
| Deweloper |
Przelicznik mRNA na SOL
Wynik | 28 |
|---|---|
Wol. – 24h | 678,56 $ |
Płynność | 2,1 tys. $ |
Posiadacze | 95 |
Audyty | |
Wiek | 2 dni |
FDV | 2 tys. $ |
Kap. rynkowa | 2 tys. $ |
Moderna Inc (mRNA)
Recent discussions on mRNA technology have been fueled by announcements from Oracle CEO Larry Ellison about the potential of AI in designing personalized mRNA vaccines for cancer treatment, sparking both interest and controversy on X. Oracle CEO Larry Ellison discussed at the White House how AI could soon design personalized mRNA vaccines for individuals to combat cancer, highlighting the promise of AI in healthcare. This announcement has led to a mix of reactions on X, with some users expressing skepticism or outright opposition to mRNA vaccines due to past experiences with COVID-19 mRNA vaccines, while others see potential in the technology for personalized medicine. The debate on X reflects broader concerns about the safety, efficacy, and ethical implications of mRNA technology, especially in light of its rapid development and application during the COVID-19 pandemic.
Aktualizuj informacje o tokenieStatystyki kursu mRNA/SOL
Bieżący kurs mRNA (mRNA/SOL) na PumpSwap wynosi 0,00000201 $, wzrósł o -0,19% w ciągu ostatnich 24 godzin. Jego 24-godzinny wolumen obrotu wynosi 678,56 $, przy 20 transakcjach. Adres kontraktu mRNA/SOL to 8PuiDczBmQuTHtwK4YjtRsViQ74hE2jKZY4ib7wrfxN2, przy w pełni rozwodnionej wycenie (FDV) 2010,19 $ i puli pula płynności 2064,49 $.
